352356-71-9 Usage
Uses
Used in Pharmaceutical Industry:
1,2,4-Thiadiazole-5-carboxylic acid, 3-methyl-, methyl ester (9CI) is used as a chemical intermediate for the synthesis of various drugs, contributing to the development of new pharmaceuticals with diverse therapeutic applications.
Used in Antimicrobial Applications:
1,2,4-Thiadiazole-5-carboxylicacid,3-methyl-,methylester(9CI) is studied for its potential antimicrobial properties, making it a candidate for use in the development of new antimicrobial agents to combat resistant bacterial strains.
Used in Antifungal Applications:
1,2,4-Thiadiazole-5-carboxylic acid, 3-methyl-, methyl ester (9CI) is explored for its antifungal capabilities, indicating its potential use in treating fungal infections and developing new antifungal medications.
Used in Anticancer Applications:
1,2,4-Thiadiazole-5-carboxylicacid,3-methyl-,methylester(9CI) has been studied for its potential anticancer properties, suggesting its use in the development of novel anticancer drugs that could target and inhibit the growth of cancer cells.
Used in Heterocyclic Compounds Synthesis:
As a building block, 1,2,4-Thiadiazole-5-carboxylic acid, 3-methyl-, methyl ester (9CI) is utilized in the synthesis of heterocyclic compounds, which are important in various chemical and pharmaceutical applications.
Used in Material Science and Chemical Processes:
This chemical has been investigated for its potential use in the development of new materials and chemical processes, indicating its versatility and applicability in advancing material science and chemical engineering fields.
Check Digit Verification of cas no
The CAS Registry Mumber 352356-71-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,2,3,5 and 6 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 352356-71:
(8*3)+(7*5)+(6*2)+(5*3)+(4*5)+(3*6)+(2*7)+(1*1)=139
139 % 10 = 9
So 352356-71-9 is a valid CAS Registry Number.
352356-71-9Relevant academic research and scientific papers
NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
-
Page/Page column 116-117, (2013/04/24)
The present invention relates to novel compounds of Formula I and their use in therapeutic treatments. The invention further relates to a novel chiral synthesis of 5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines using N-sp3 protective groups. The invention also provides intermediates for use in the synthesis of compounds of Formula I.
